CN113784724A - 使用可吞咽药品递送装置将药品递送到肠道内腔中的治疗剂制剂和方法 - Google Patents
使用可吞咽药品递送装置将药品递送到肠道内腔中的治疗剂制剂和方法 Download PDFInfo
- Publication number
- CN113784724A CN113784724A CN202080028733.XA CN202080028733A CN113784724A CN 113784724 A CN113784724 A CN 113784724A CN 202080028733 A CN202080028733 A CN 202080028733A CN 113784724 A CN113784724 A CN 113784724A
- Authority
- CN
- China
- Prior art keywords
- insulin
- capsule
- formulation
- drug
- balloon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962818053P | 2019-03-13 | 2019-03-13 | |
| US62/818,053 | 2019-03-13 | ||
| US201962820174P | 2019-03-18 | 2019-03-18 | |
| US62/820,174 | 2019-03-18 | ||
| PCT/US2020/022496 WO2020186121A1 (en) | 2019-03-13 | 2020-03-12 | Therapeutic agent preparations and methods for drug delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113784724A true CN113784724A (zh) | 2021-12-10 |
Family
ID=72424820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080028733.XA Pending CN113784724A (zh) | 2019-03-13 | 2020-03-12 | 使用可吞咽药品递送装置将药品递送到肠道内腔中的治疗剂制剂和方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200289620A1 (enExample) |
| EP (1) | EP3937971A4 (enExample) |
| JP (1) | JP2022524446A (enExample) |
| KR (1) | KR20210138646A (enExample) |
| CN (1) | CN113784724A (enExample) |
| AU (1) | AU2020237517A1 (enExample) |
| BR (1) | BR112021017993A2 (enExample) |
| CA (1) | CA3133086A1 (enExample) |
| MX (1) | MX2021011047A (enExample) |
| WO (1) | WO2020186121A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8721620B2 (en) | 2009-12-24 | 2014-05-13 | Rani Therapeutics, Llc | Swallowable drug delivery device and methods of drug delivery |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| AU2018366110B2 (en) * | 2017-11-07 | 2024-08-08 | Rani Therapeutics, Llc | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
| CN112451500B (zh) * | 2020-12-18 | 2022-05-17 | 南京鼓楼医院 | 一种磁响应载药微针机器人及其制备方法和应用 |
| WO2025081168A1 (en) * | 2023-10-12 | 2025-04-17 | The Brigham And Women's Hospital, Inc. | An intra-abdominal injection system |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110160699A1 (en) * | 2009-12-24 | 2011-06-30 | Incube Labs, Llc | Swallowable Drug Delivery Device and Methods of Drug Delivery |
| US20150329630A1 (en) * | 2014-05-15 | 2015-11-19 | Incube Labs, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| US20170051051A1 (en) * | 2014-05-15 | 2017-02-23 | Rani Therapeutics, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| CN108055826A (zh) * | 2015-07-02 | 2018-05-18 | 拉尼医疗有限公司 | 用于使用可吞服药物递送装置递送到肠道内腔中的治疗药剂制剂 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8809269B2 (en) * | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) * | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402807B2 (en) * | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8980822B2 (en) * | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) * | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9284367B2 (en) * | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8969293B2 (en) * | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) * | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9149617B2 (en) * | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9283179B2 (en) * | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10639272B2 (en) * | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9629799B2 (en) * | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9861683B2 (en) * | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) * | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US20230374155A1 (en) * | 2014-05-15 | 2023-11-23 | Rani Therapeutics, Llc | Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) * | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US11548940B2 (en) * | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| AU2018366110B2 (en) * | 2017-11-07 | 2024-08-08 | Rani Therapeutics, Llc | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
| US11473339B2 (en) * | 2018-01-31 | 2022-10-18 | Spectrum Brands, Inc. | Field-handable gate latch |
| CN113543756B (zh) * | 2018-12-31 | 2023-09-05 | 拉尼医疗有限公司 | 使用可吞服药物递送装置递送到肠道内腔的治疗剂制剂 |
| CA3137539A1 (en) * | 2019-05-03 | 2020-10-20 | Rani Therapeutics, Llc | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
-
2020
- 2020-03-12 BR BR112021017993A patent/BR112021017993A2/pt unknown
- 2020-03-12 CN CN202080028733.XA patent/CN113784724A/zh active Pending
- 2020-03-12 KR KR1020217032196A patent/KR20210138646A/ko not_active Abandoned
- 2020-03-12 CA CA3133086A patent/CA3133086A1/en active Pending
- 2020-03-12 EP EP20770263.0A patent/EP3937971A4/en not_active Withdrawn
- 2020-03-12 JP JP2021554738A patent/JP2022524446A/ja active Pending
- 2020-03-12 US US16/817,490 patent/US20200289620A1/en not_active Abandoned
- 2020-03-12 AU AU2020237517A patent/AU2020237517A1/en not_active Abandoned
- 2020-03-12 WO PCT/US2020/022496 patent/WO2020186121A1/en not_active Ceased
- 2020-03-12 MX MX2021011047A patent/MX2021011047A/es unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110160699A1 (en) * | 2009-12-24 | 2011-06-30 | Incube Labs, Llc | Swallowable Drug Delivery Device and Methods of Drug Delivery |
| US20150329630A1 (en) * | 2014-05-15 | 2015-11-19 | Incube Labs, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| US20170051051A1 (en) * | 2014-05-15 | 2017-02-23 | Rani Therapeutics, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| CN108055826A (zh) * | 2015-07-02 | 2018-05-18 | 拉尼医疗有限公司 | 用于使用可吞服药物递送装置递送到肠道内腔中的治疗药剂制剂 |
Non-Patent Citations (1)
| Title |
|---|
| 臧彦楠等: "肠促胰岛素相关药物的药代动力学/药效学模型研究进展", 中国临床药理学杂志, vol. 31, no. 02, 31 January 2015 (2015-01-31), pages 146 - 149 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020237517A1 (en) | 2021-10-14 |
| US20200289620A1 (en) | 2020-09-17 |
| AU2020237517A2 (en) | 2021-11-04 |
| EP3937971A1 (en) | 2022-01-19 |
| KR20210138646A (ko) | 2021-11-19 |
| EP3937971A4 (en) | 2022-12-14 |
| MX2021011047A (es) | 2021-12-15 |
| BR112021017993A2 (pt) | 2022-01-18 |
| CA3133086A1 (en) | 2020-09-17 |
| JP2022524446A (ja) | 2022-05-02 |
| WO2020186121A1 (en) | 2020-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11844867B2 (en) | Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device | |
| JP7616937B2 (ja) | 嚥下可能薬物送達デバイスおよび薬物送達方法 | |
| US20240001094A1 (en) | Preparation comprising exanatide for delivery into a lumen of the intestinal tract | |
| US10004783B2 (en) | Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device | |
| CN109008910B (zh) | 用于使用可吞服药物递送装置递送到肠道内腔中的治疗药剂制剂 | |
| US9486414B2 (en) | Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device | |
| CN113784724A (zh) | 使用可吞咽药品递送装置将药品递送到肠道内腔中的治疗剂制剂和方法 | |
| CN113543756B (zh) | 使用可吞服药物递送装置递送到肠道内腔的治疗剂制剂 | |
| CN108055826A (zh) | 用于使用可吞服药物递送装置递送到肠道内腔中的治疗药剂制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20211210 |
|
| WD01 | Invention patent application deemed withdrawn after publication |